(2) FIGO stage was determined by tumor location, tumor size, lymph node metastasis, and pathologic metastasis; meanwhile, TRPC1 would facilitate cancer development and progression in EC.15, 23. This evidence concerns the gene TRPC1 and metastatic malignant neoplasm in the lymph nodes.